About Us
Our purpose is to provide products and services to improve the quality of life of people. We use science and technology to address existing healthcare issues.
Central R&D Center
Research projects
Classification
Code
Indications
Development Phase
New drug
YP-P10
Xerophthalmia
Incrementally modified drug
YY-2311
Benign prostatic hyperplasia
YY-2312
Benign prostatic hyperplasia
Generic -ETC
YY-3311
Benign prostatic hyperplasia
YY-3314
Benign prostatic hyperplasia
YY-3940
Dermatomycosis
YY-3450
Osteoporosis
YY-3340
Hyperparathyroidisim
YY-3134
Hyperlipidemia
YY-3993
Bacterial infections
YY-3220
Spasmodic pain
YY-3136
Hypertriglyceridemia
Products released in last three years (2023 to 2025)
| Category | Product name | Release date |
|---|---|---|
| Products released in 2023 | NOIROMIN Tablet | February |
| NEWXIGA Tablet | April | |
| FEXOGIEN Tablet 60mg | September | |
| TANAMIN Tablet 240mg | October | |
| Products released in 2024 | ALLESTAR Tablet 120mg | August |
| MYGRAN Tablet 25mg | October | |
| Products released in 2025 | FEXOONE Tablet 180mg | February |
| ALFAKY Soft Capsule 0.5mcg, 1.0mcg | October |
